Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Vet Ophthalmol. 2011 Apr 18;14(5):304–312. doi: 10.1111/j.1463-5224.2011.00877.x

Figure 2.

Figure 2

Percent viability of canine stromal fibroblasts (CSFs) treated with increasing doses of mitomycin C (MMC). CSFs treated with various concentrations of MMC were stained with trypan blue reagent to count the number of viable cells. MMC dose of 0.002% and 0.02% only slightly decreased cellular viability but were not statistically significant. However, 0.04% significantly reduced the cellular viability up to 27% (P < 0.001). Error bars indicate standard error.